Evaluation of antihyperalgesic and analgesic effects of 35% nitrous oxide when combined with remifentanil A randomised phase 1 trial in volunteers
Wehrfritz A, Bauer M, Noel N, Ramirez-Gil JF, Ihmsen H, Prottengeier J, Schüttler J, Bessiere B (2021)
Publication Type: Journal article
Publication year: 2021
Journal
Book Volume: 38
Pages Range: 1230-1241
Journal Issue: 12
DOI: 10.1097/EJA.0000000000001468
Abstract
BACKGROUND Remifentanil is an effective drug in peri-operative pain therapy, but it can also induce and aggravate hyperalgesia. Supplemental administration of N2O may help to reduce remifentanil-induced hyperalgesia.
Authors with CRIS profile
Marcus Bauer
Lehrstuhl für Rechtsmedizin
Harald Ihmsen
Department of Anaesthesiology
Johannes Prottengeier
Department of Anaesthesiology
Jürgen Schüttler
Lehrstuhl für Anästhesiologie
Involved external institutions
France (FR)How to cite
APA:
Wehrfritz, A., Bauer, M., Noel, N., Ramirez-Gil, J.F., Ihmsen, H., Prottengeier, J.,... Bessiere, B. (2021). Evaluation of antihyperalgesic and analgesic effects of 35% nitrous oxide when combined with remifentanil A randomised phase 1 trial in volunteers. European Journal of Anaesthesiology, 38(12), 1230-1241. https://doi.org/10.1097/EJA.0000000000001468
MLA:
Wehrfritz, Andreas, et al. "Evaluation of antihyperalgesic and analgesic effects of 35% nitrous oxide when combined with remifentanil A randomised phase 1 trial in volunteers." European Journal of Anaesthesiology 38.12 (2021): 1230-1241.
BibTeX: Download